Progesterone Therapy in Pre‐Eclamptic Toxaemia

9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abstract. Progesterone was the principal therapeutic agent used in 40 cases of pre‐eclamptic toxaemia. It was also given to 10 normal pregnant women who served as a control group. A significant fall in both the systolic and diastolic blood pressures was observed in 80% of the toxaemic patients. In all cases there was a marked increase in the 24‐hour urinary output with an apparent loss of weight. Serum uric acid showed a significant drop and the urea clearance values also improved. The serum sodium showed an apparent decline while the serum potassium did not show any marked variation. The serum uric acid, urea clearance, blood urea, serum sodium and serum potassium remained unchanged in the control group. 1975 Acta Obstet Gynecol Scand

Cite

CITATION STYLE

APA

Sammour, M. B., El‐Kabarity, H., & Khalifa, A. S. (1975). Progesterone Therapy in Pre‐Eclamptic Toxaemia. Acta Obstetricia et Gynecologica Scandinavica, 54(3), 195–202. https://doi.org/10.3109/00016347509157760

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free